Literature DB >> 17332893

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Tomas Vaisar1, Subramaniam Pennathur, Pattie S Green, Sina A Gharib, Andrew N Hoofnagle, Marian C Cheung, Jaeman Byun, Simona Vuletic, Sean Kassim, Pragya Singh, Helen Chea, Robert H Knopp, John Brunzell, Randolph Geary, Alan Chait, Xue-Qiao Zhao, Keith Elkon, Santica Marcovina, Paul Ridker, John F Oram, Jay W Heinecke.   

Abstract

HDL lowers the risk for atherosclerotic cardiovascular disease by promoting cholesterol efflux from macrophage foam cells. However, other antiatherosclerotic properties of HDL are poorly understood. To test the hypothesis that the lipoprotein carries proteins that might have novel cardioprotective activities, we used shotgun proteomics to investigate the composition of HDL isolated from healthy subjects and subjects with coronary artery disease (CAD). Unexpectedly, our analytical strategy identified multiple complement-regulatory proteins and a diverse array of distinct serpins with serine-type endopeptidase inhibitor activity. Many acute-phase response proteins were also detected, supporting the proposal that HDL is of central importance in inflammation. Mass spectrometry and biochemical analyses demonstrated that HDL3 from subjects with CAD was selectively enriched in apoE, raising the possibility that HDL carries a unique cargo of proteins in humans with clinically significant cardiovascular disease. Collectively, our observations suggest that HDL plays previously unsuspected roles in regulating the complement system and protecting tissue from proteolysis and that the protein cargo of HDL contributes to its antiinflammatory and antiatherogenic properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332893      PMCID: PMC1804352          DOI: 10.1172/JCI26206

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

2.  Targeting C-reactive protein for the treatment of cardiovascular disease.

Authors:  Mark B Pepys; Gideon M Hirschfield; Glenys A Tennent; J Ruth Gallimore; Melvyn C Kahan; Vittorio Bellotti; Philip N Hawkins; Rebecca M Myers; Martin D Smith; Alessandra Polara; Alexander J A Cobb; Steven V Ley; J Andrew Aquilina; Carol V Robinson; Isam Sharif; Gillian A Gray; Caroline A Sabin; Michelle C Jenvey; Simon E Kolstoe; Darren Thompson; Stephen P Wood
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

Review 3.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

4.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

Authors:  Timothy E Graham; Qin Yang; Matthias Blüher; Ann Hammarstedt; Theodore P Ciaraldi; Robert R Henry; Christopher J Wason; Andreas Oberbach; Per-Anders Jansson; Ulf Smith; Barbara B Kahn
Journal:  N Engl J Med       Date:  2006-06-15       Impact factor: 91.245

5.  Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: role of apoE.

Authors:  K L Olin; S Potter-Perigo; P H Barrett; T N Wight; A Chait
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

6.  Direct analysis of protein complexes using mass spectrometry.

Authors:  A J Link; J Eng; D M Schieltz; E Carmack; G J Mize; D R Morris; B M Garvik; J R Yates
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

7.  HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway.

Authors:  Fumihiko Matsuura; Nan Wang; Wengen Chen; Xian-Cheng Jiang; Alan R Tall
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

8.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

9.  Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro.

Authors:  R C Strunk; K S Kunke; P C Giclas
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

Review 10.  Paraoxonase, a cardioprotective enzyme: continuing issues.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Curr Opin Lipidol       Date:  2004-06       Impact factor: 4.776

View more
  353 in total

Review 1.  Time to ditch HDL-C as a measure of HDL function?

Authors:  Graziella E Ronsein; Jay W Heinecke
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

2.  Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein.

Authors:  Timothy J Sontag; Ronald Carnemolla; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2012-03-08       Impact factor: 5.922

3.  Using bioinformatics and systems genetics to dissect HDL-cholesterol genetics in an MRL/MpJ x SM/J intercross.

Authors:  Magalie S Leduc; Rachael Hageman Blair; Ricardo A Verdugo; Shirng-Wern Tsaih; Kenneth Walsh; Gary A Churchill; Beverly Paigen
Journal:  J Lipid Res       Date:  2012-04-11       Impact factor: 5.922

4.  BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α.

Authors:  Diego A Rodriguez; Sebastian Zamorano; Fernanda Lisbona; Diego Rojas-Rivera; Hery Urra; Juan R Cubillos-Ruiz; Ricardo Armisen; Daniel R Henriquez; Emily H Cheng; Michal Letek; Tomas Vaisar; Thergiory Irrazabal; Christian Gonzalez-Billault; Anthony Letai; Felipe X Pimentel-Muiños; Guido Kroemer; Claudio Hetz
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598

5.  Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry.

Authors:  Matthew T Mazur; Helene L Cardasis; Daniel S Spellman; Andy Liaw; Nathan A Yates; Ronald C Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-13       Impact factor: 11.205

Review 6.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

Review 7.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

8.  High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.

Authors:  Masashi Suzuki; David K Pritchard; Lev Becker; Andrew N Hoofnagle; Natsuko Tanimura; Theo K Bammler; Richard P Beyer; Roger Bumgarner; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; Kensuke Miyake; John F Oram; Jay W Heinecke
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

9.  Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation.

Authors:  Nadia H Moore; Lucio G Costa; Scott A Shaffer; David R Goodlett; Marina Guizzetti
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

10.  High serum apolipoprotein E determines hypertriglyceridemic dyslipidemias, coronary disease and apoA-I dysfunctionality.

Authors:  Altan Onat; Günay Can; Ender Ornek; Erkan Ayhan; Nihan Erginel-Ünaltuna; Sani N Murat
Journal:  Lipids       Date:  2012-10-25       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.